DGAP-Adhoc: Cytos Biotechnology Ltd to wind down Key Operational Activities
Cytos Biotechnology AG / Key word(s): Strategic Company Decision 05.05.2014 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehr
Storys aus Schlieren
-
Sprache:
Englisch
-
Medien:
Alle
- Zeitraum:
- Zeitraum:Gesamt
DGAP-Adhoc: Cytos Biotechnology Ltd (SIX:CYTN) today published the topline results of the global Phase 2b clinical trial with CYT003.
Cytos Biotechnology AG / Key word(s): Research Update 14.04.2014 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-Adhoc: Annual Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders approved all proposals and resolutions
Cytos Biotechnology AG / Key word(s): AGM/EGM 03.04.2014 15:14 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-Adhoc: Cytos Biotechnology Ltd announces amendment of convertible loan notes agreement
Cytos Biotechnology AG / Key word(s): Bond 31.03.2014 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-Adhoc: Cytos Biotechnology Ltd invites to the Annual Shareholders' Meeting in April 2014
Cytos Biotechnology AG / Key word(s): AGM/EGM 13.03.2014 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-Adhoc: Cytos Biotechnology Ltd announces full year 2013 financial results
Cytos Biotechnology AG / Key word(s): Final Results 13.02.2014 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-Adhoc: Cytos Biotechnology Ltd: Singapore's first influenza vaccine demonstrates favourable immunogenicity and tolerability
Cytos Biotechnology AG / Key word(s): Research Update/Study 29.01.2014 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-Adhoc: Cytos Biotechnology Ltd - Extraordinary Shareholders' Meeting - All Resolutions Approved
Cytos Biotechnology AG / Key word(s): AGM/EGM 30.12.2013 13:35 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-News: Cytos Biotechnology Ltd invites to an Extraordinary Shareholders' Meeting in December 2013
EQS Group-News: Cytos Biotechnology AG / Key word(s): AGM/EGM Cytos Biotechnology Ltd invites to an Extraordinary Shareholders' Meeting in December 2013 04.12.2013 / 07:00 242954 04.12.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd - Rights offering oversubscribed - CHF 24.3 million raised
EQS Group-News: Cytos Biotechnology AG / Key word(s): Capital Increase Cytos Biotechnology Ltd - Rights offering oversubscribed - CHF 24.3 million raised 18.11.2013 / 07:00 240316 18.11.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd announces terms for capital increase
EQS Group-News: Cytos Biotechnology AG / Key word(s): Capital Increase Cytos Biotechnology Ltd announces terms for capital increase 05.11.2013 / 07:00 237764 05.11.2013 ...
mehrDGAP-Adhoc: Extraordinary Shareholders' Meeting of Cytos Biotechnology Ltd: Shareholders approved all resolutions
Cytos Biotechnology AG / Key word(s): Capital Increase 04.11.2013 12:29 Release of an ad hoc announcement pursuant to Art. 53 KR ...
mehrDGAP-News: Cytos Biotechnology Ltd: Third Quarter Report 2013
EQS Group-News: Cytos Biotechnology AG / Key word(s): Quarter Results Cytos Biotechnology Ltd: Third Quarter Report 2013 31.10.2013 / 07:00 236973 31.10.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd announced the completion of patient enrolment of the on-going Phase 2b study of CYT003
EQS Group-News: Cytos Biotechnology AG / Key word(s): Research Update Cytos Biotechnology Ltd announced the completion of patient enrolment of the on-going Phase 2b study of CYT003 21.10.2013 / 07:00 235324 21.10.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd announces hosting of Investor & Analyst Day in NYC
EQS Group-News: Cytos Biotechnology AG / Key word(s): Research Update Cytos Biotechnology Ltd announces hosting of Investor & Analyst Day in NYC 17.10.2013 / 18:00 235119 17.10.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd announces financing transaction
EQS Group-News: Cytos Biotechnology AG / Key word(s): Capital Increase Cytos Biotechnology Ltd announces financing transaction 10.10.2013 / 07:00 233991 10.10.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd (SIX:CYTN) today presents additional results from its Phase 2a study of CYT003 for the treatment of allergic asthma
EQS Group-News: Cytos Biotechnology AG / Key word(s): Research Update Cytos Biotechnology Ltd (SIX:CYTN) today presents additional results from its Phase 2a study of CYT003 for the treatment of allergic asthma 09.09.2013 / 07:00 229498 09.09.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd: Second Quarter Report 2013 / Highlights
EQS Group-News: Cytos Biotechnology AG / Key word(s): Half Year Results Cytos Biotechnology Ltd: Second Quarter Report 2013 / Highlights 06.08.2013 / 07:00 224290 06.08.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd, Annual Shareholders' Meeting: Shareholders approved all proposals and resolutions. (with additional features)
EQS Group AG-News: Cytos Biotechnology AG / Key word(s): AGM/EGM Cytos Biotechnology Ltd, Annual Shareholders' Meeting: Shareholders approved all proposals and resolutions. (with additional features) 28.06.2013 / 19:00 218808 28.06.2013 ...
mehrDGAP-News: Cytos Biotechnology Ltd invites to the Annual Shareholders' Meeting 2013 (with additional features)
EquityStory AG-News: Cytos Biotechnology AG / Key word(s): AGM/EGM Cytos Biotechnology Ltd invites to the Annual Shareholders' Meeting 2013 (with additional features) 06.06.2013 / 07:00 215041 06.06.2013 ...
mehrPrionics and Bio-X Diagnostics form strategic partnership
Schlieren-Zurich, Switzerland (ots) - Prionics, a world leader in farm animal diagnostics, has entered into a strategic partnership with the Belgian company Bio-X Diagnostics to make their innovative diagnostic solutions available to global markets. The collaboration will include distribution, product development and production. Through this partnership, Prionics and Bio-X Diagnostics customers will profit from an ...
mehrPrionics: Favourable assessment of BOVIGAM® tuberculosis test in Europe
Schlieren-Zurich (ots) - The European Food Safety Authority (EFSA) has reviewed field performance data of the BOVIGAM® Interferon-y (IFN-y) test and recommends IFN-y tests for inclusion in the official list of stand-alone tests for bovine tuberculosis (TB). BOVIGAM® is currently widely used as a supplementary test to complement skin testing. Prionics trusts that the ...
mehrPrionics: New test to combat scrapie and mad cow disease in sheep and goats
Schlieren-Zurich (ots) - An innovative new test is now available to detect TSE (scrapie and mad cow disease) in sheep and goats. With the Prionics®-Check PrioSTRIP SR, Prionics brings to the market the first test to achieve high diagnostic sensitivity on preclinical TSE cases. The test was approved today by the European Commission for use in TSE testing in small ...
mehr
Vorherige12